ArticleCellular oncology (Dordrecht, Netherlands)2025

Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression.

Xiao-Mei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.